CN1938589B - Method and apparatus for implementing threshold based correction functions for biosensors - Google Patents
Method and apparatus for implementing threshold based correction functions for biosensors Download PDFInfo
- Publication number
- CN1938589B CN1938589B CN2005800102926A CN200580010292A CN1938589B CN 1938589 B CN1938589 B CN 1938589B CN 2005800102926 A CN2005800102926 A CN 2005800102926A CN 200580010292 A CN200580010292 A CN 200580010292A CN 1938589 B CN1938589 B CN 1938589B
- Authority
- CN
- China
- Prior art keywords
- correction function
- value
- threshold value
- coefficient
- action
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
技术领域 technical field
一般而言,本发明涉及生物传感器,更具体地,涉及一种方法和装置,其用于实现用于生物传感器的、基于阈值的校正函数。The present invention relates generally to biosensors and, more particularly, to a method and apparatus for implementing a threshold-based correction function for a biosensor.
背景技术 Background technique
对体液中待分析物进行定量测定在对某些生理异常的诊断和养护中是很重要的。例如需要监测某些个体中的乳酸、胆固醇、胆红素。具体而言,对于需要经常检查其体液中葡萄糖水平,以调节其膳食葡萄糖摄入的糖尿病个体来说,对体液中葡萄糖的测定是很重要的。虽然本申请公开文本的其余部分将针对对葡萄糖的测定,但是应当理解,在选择合适的酶的基础上,本发明的工序和设备可被用于测定其它待分析物。对流体中葡萄糖进行检测的理想诊断设备应当是简单的,对开展该化验的部分技术人员的技术水平不应有高要求。在很多情况下,这些化验是由患者来进行的,因此更为需要易于进行的化验。此外,此种设备应当基于稳定到足以长时间保存的成分。Quantitative determination of analytes in body fluids is important in the diagnosis and management of certain physiological abnormalities. For example lactate, cholesterol, bilirubin need to be monitored in certain individuals. In particular, the measurement of glucose in body fluids is important for diabetic individuals who need to frequently check their glucose levels in body fluids to regulate their dietary glucose intake. While the remainder of this disclosure will be directed to the determination of glucose, it should be understood that the procedures and devices of the present invention can be used to measure other analytes upon selection of an appropriate enzyme. Ideal diagnostic equipment for the detection of glucose in fluids should be simple and should not require a high level of skill on the part of the technicians performing the assay. In many cases, these assays are performed by the patient, thus increasing the need for assays that are easy to perform. Furthermore, such devices should be based on ingredients that are stable enough for long-term storage.
用于测定流体中待分析物浓度的方法可以基于酶和特异于该酶的待分析物以及将该酶保持为其初始氧化态的介质(mediator)之间的电化学反应。合适的氧化还原酶包括:氧化酶、脱氢酶、过氧化氢酶(catalase)和过氧化物酶。例如,当葡萄糖是待分析物的情况下,葡萄糖氧化酶和氧之间的反应由方程式(A)所代表。A method for determining the concentration of an analyte in a fluid may be based on an electrochemical reaction between an enzyme and an analyte specific for the enzyme and a mediator that maintains the enzyme in its original oxidized state. Suitable oxidoreductases include: oxidases, dehydrogenases, catalases and peroxidases. For example, when glucose is the analyte, the reaction between glucose oxidase and oxygen is represented by equation (A).
(A)(A)
在比色试验中,存在过氧化物酶的情况下,释放出的过氧化氢导致氧化还原指示剂颜色的变化,其中,颜色变化与测试流体中葡萄糖水平成比例关系。尽管通过使用色表对氧化还原指示剂的颜色变化与用已知葡萄糖浓度的测试流体获得的颜色变化加以比较,从而半定量地进行比色化验时,并且可通过用分光光度设备读取结果从而更高水平地定量进行比色化验时,其结果通常既没有用电化学生物传感器所获得的结果精确,也不如后者迅速。本文中使用的术语“生物传感器系统”指一种分析设备,其对适当的样品中的待分析物选择性应答,将其浓度转变为电信号,这是通过生物识别信号和物理-化学换能器(transducer)的组合来实现的。In a colorimetric test, the release of hydrogen peroxide in the presence of peroxidase results in a change in the color of the redox indicator, where the color change is proportional to the level of glucose in the test fluid. Although colorimetric assays are performed semi-quantitatively by using a color table to compare the color change of a redox indicator to that obtained with a test fluid of known glucose concentration, and can be read by spectrophotometric equipment to When colorimetric assays are performed at higher levels of quantification, the results are generally neither as precise nor as rapid as those obtained with electrochemical biosensors. As used herein, the term "biosensor system" refers to an analytical device that selectively responds to an analyte in an appropriate sample, converting its concentration into an electrical signal, through biorecognition signals and physico-chemical transduction It is realized by a combination of transducers.
H2O2→O2+2H++2e- H 2 O 2 →O 2 +2H + +2e -
(B)(B)
然后将电流转化为与葡萄糖浓度直接相关的电信号。The current is then converted into an electrical signal that is directly related to glucose concentration.
在方程式(A)代表的反应的最初步骤中,测试样品中存在的葡萄糖将酶的被氧化的黄素腺嘌呤二核苷酸(FAD)中心转化为其还原形式(FADH2)。因为这些氧化还原中心在酶分子中基本都是电绝缘的,所以在不存在不可接受的过高电压的情况下,就不会发生任何达到可被测量出的程度的、到传统电极表面的直接电子转移。对该系统的改进包括,在电极和酶之间使用非生理性的氧化还原耦合,以在(FADH2)和电极之间穿梭电子。这是由下述流程来代表的,其中,氧化还原耦合剂(coupler)(典型地,被称为介质)由M所代表:In the initial step of the reaction represented by equation (A), glucose present in the test sample converts the oxidized flavin adenine dinucleotide (FAD) center of the enzyme to its reduced form ( FADH2 ). Because these redox centers are essentially electrically insulating in the enzyme molecule, any direct transfer to the surface of conventional electrodes does not occur to measurable levels in the absence of unacceptably high voltages. electron transfer. Modifications to this system include the use of non-physiological redox coupling between the electrode and the enzyme to shuttle electrons between ( FADH2 ) and the electrode. This is represented by the following scheme, where a redox coupler (typically, called a mediator) is represented by M:
葡萄糖+GO(FAD)→葡萄糖内酯+GO(FADH2)Glucose+GO(FAD)→Glucolactone+GO(FADH 2 )
GO(FADH2)+2MOX→GO(FAD)+2Mred+2H+ GO(FADH 2 )+2M OX →GO(FAD)+2M red +2H +
2Mred→2MO×+2e-(在电极上)2M red → 2M O× +2e - (on electrodes)
在该流程中,GO(FAD)代表葡萄糖氧化酶的氧化形式,GO(FADH2)代表其还原形式。起介质作用的物质Mred将电子从被还原的酶穿梭到电极,由此氧化该酶,导致其原位再生,就经济方面的原因而言,这当然是人们想要的。使用介质的主要目的是降低传感器的工作电势。理想的介质能在低电势下在电极上被氧化还原,在所述低电势下,化学层中的杂质和样品中的妨碍物质将不会被氧化,由此使得干扰最小化。In this scheme, GO(FAD) represents the oxidized form of glucose oxidase and GO(FADH 2 ) represents its reduced form. The mediator substance M red shuttles electrons from the reduced enzyme to the electrode, thereby oxidizing the enzyme, leading to its regeneration in situ, which is of course desirable for economical reasons. The main purpose of using a medium is to lower the operating potential of the sensor. An ideal medium would be redoxed at the electrodes at low potentials where impurities in the chemical layer and interfering species in the sample would not be oxidized, thereby minimizing interference.
因为能够从被还原的酶接受电子并将它们转移到电极,很多种化合物都可用作为介质。已知可在分析测定中用作为电子转移试剂的介质是,U.S.专利4,746,607中公开的被取代的苯醌或萘醌;N-氧化物、亚硝基化合物、羟胺和喔星(oxines),具体公开于EP 0 354 441中;EP 0 330 517中公开的黄素、吩嗪、吩噻嗪、靛酚、被取代的1,4-苯醌和吲达胺;以及U.S.专利3,791,988中描述的吩嗪鎓/吩噁嗪鎓盐。对于生物氧化还原系统中电化学介质的综述,可参见Analytica ClinicaActa.140(1982),Pp1-18。Because of the ability to accept electrons from the reduced enzyme and transfer them to the electrode, a wide variety of compounds can be used as mediators. Mediators known to be useful as electron transfer reagents in analytical assays are substituted benzoquinones or naphthoquinones disclosed in US Patent 4,746,607; N-oxides, nitroso compounds, hydroxylamines and oxines, specifically Flavins, phenazines, phenothiazines, indophenols, substituted 1,4-benzoquinones and indamines disclosed in
更著名的介质是六氰基铁酸盐(hexacyanoferrate),其也被称为铁氰化物,在等人,Clinica Chimica Acta.,57(1974),Pp.283-289中有所讨论。在U.S.专利4,929,545中公开了一种可溶的铁氰化物化合物与可溶的含铁化合物在组合物中组合起来的用途,用于通过酶对样品中待分析物进行测定。用铁氰化物的铁盐取代方程式(A)中的氧,提供了如下方程式:A better known agent is hexacyanoferrate, also known as ferricyanide, found in Discussed in et al., Clinica Chimica Acta ., 57 (1974), pp. 283-289. US Patent No. 4,929,545 discloses the use of a combination of a soluble ferricyanide compound and a soluble iron-containing compound in a composition for the determination of an analyte in a sample by an enzyme. Substituting the iron salt of ferricyanide for the oxygen in equation (A) provides the following equation:
因为接受了来自葡萄糖氧化酶的电子,铁氰化物被还原为亚铁氰化物。Ferricyanide is reduced to ferrocyanide by accepting electrons from glucose oxidase.
另一条表达该反应的路径可以用下述方程式C来表示Another way to express this reaction can be represented by the following equation C
葡萄糖+GOX(OX)→葡萄糖内酯+GOX(red) Glucose + GO X(OX) → Glucolactone + GO X(red)
GOX(red)+2Fe(CN3)3- 6→GOX(OX)+2Fe(CN)4-+2e- GO X(red) +2Fe(CN 3 ) 3- 6 →GO X(OX) +2Fe(CN) 4- +2e -
(C)(C)
释放的电子直接等价于待测流体中葡萄糖的量,可通过对在流体上施加电压而在流体中产生的电流进行测量,将所述释放的电子与所述葡萄糖的量相关起来。亚铁氰化物在阳极上的氧化使得该循环更新。The released electrons are directly equivalent to the amount of glucose in the fluid to be measured, and can be correlated to the amount of glucose by measuring the current generated in the fluid by applying a voltage to the fluid. Oxidation of ferrocyanide at the anode renews the cycle.
公告于2002年5月21日的Huang等人的U.S.专利6,391,645已被转让给本受让人,其中公开了一种方法和装置,用于校正生物传感器中环境温度的影响。其测量了环境温度的值。将样品应用到生物传感器上,然后测量待测样品中产生的电流。通过标准应答曲线,从电流来计算观察得到的待分析物浓度的值。然后用测得的环境温度值来修正观察得到的待分析物浓度,由此增加对待分析物测定的精确度。可以通过解下列方程式来计算出待分析物的浓度:U.S. Patent 6,391,645 to Huang et al., issued May 21, 2002, assigned to the present assignee, discloses a method and apparatus for correcting for the effect of ambient temperature in a biosensor. It measures the value of the ambient temperature. The sample is applied to the biosensor and the electrical current generated in the sample to be tested is measured. Values for the observed analyte concentrations were calculated from the currents by standard response curves. The measured ambient temperature value is then used to correct the observed analyte concentration, thereby increasing the accuracy of the analyte determination. The concentration of the analyte can be calculated by solving the following equation:
G2=(G1-(T2 2-242)*12-(T2-24)*11)/G2=(G1-(T 2 2 -24 2 )*12-(T 2 -24)*11)/
((T2 2-242)*S2+(T2-24)*S1+1)((T 2 2 -24 2 )*S2+(T 2 -24)*S1+1)
其中,G1是所述观察得到的待分析物浓度值,T2是所述测得的环境温度值,I1、I2、S1和S2是预先设定的参数。Wherein, G1 is the observed concentration value of the analyte, T2 is the measured ambient temperature value, and I1, I2, S1 and S2 are preset parameters.
虽然U.S.专利6,391,645的方法和装置提供了对于测定待分析物的精确度方面的改进,但是,人们仍需要能用于测量待分析物浓度的任何体系的改进的校正机制。While the method and apparatus of U.S. Patent 6,391,645 provide improvements in the accuracy of determining analytes, there remains a need for improved calibration mechanisms that can be used in any system that measures analyte concentrations.
用于下述说明书和权利要求书中的术语“生物传感器”指电化学传感器带(strip)或分析设备的传感器组件或生物传感器系统,其能对适当的样品中的待分析物做出选择性应答,并将其浓度转变为电信号。生物传感器直接产生电信号,这使得仪器的设计变得简单。此外,生物传感器还提供了低材料成本的优势,因为仅有薄层化学物质沉积到电极上,浪费的材料很少。The term "biosensor" as used in the following specification and claims refers to an electrochemical sensor strip (strip) or sensor assembly of an analytical device or a biosensor system that is capable of making selectivity for an analyte in an appropriate sample response and convert its concentration into an electrical signal. Biosensors generate electrical signals directly, which simplifies instrument design. In addition, biosensors offer the advantage of low material costs because only thin layers of chemicals are deposited on the electrodes, with little wasted material.
术语“样品”被定义为含有未知量的目标待分析物的组合物。典型地,用于电化学分析的样品是液体形式的,优选地,该样品是水性混合物。样品可以是生物样品,例如,血、尿或唾液。样品可以是生物样品的衍生物,例如,提取物、稀释液、滤出物或重新构成的沉淀。The term "sample" is defined as a composition containing an unknown amount of an analyte of interest. Typically, samples for electrochemical analysis are in liquid form, preferably, the sample is an aqueous mixture. The sample can be a biological sample, eg blood, urine or saliva. A sample can be a derivative of a biological sample, eg, an extract, dilution, filtrate, or reconstituted precipitate.
术语“待分析物”被定义为样品中的物质,其存在或含量将被测定。分析期间,待分析物与存在的氧化还原酶发生相互作用,其可以是氧化还原酶的底物、辅酶或影响到氧化还原酶与其底物之间相互作用的另一种物质。The term "analyte" is defined as a substance in a sample, the presence or amount of which is to be determined. During analysis, the analyte interacts with the oxidoreductase present, which may be a substrate of the oxidoreductase, a coenzyme, or another substance that affects the interaction between the oxidoreductase and its substrate.
发明内容 Contents of the invention
本发明的重要方面是提供一种新的、经过改进的生物传感器系统,用于测定样品中物质的存在或含量,其包括一种方法和装置,用于实现用于生物传感器的、基于阈值的校正函数。An important aspect of the present invention is to provide a new and improved biosensor system for determining the presence or amount of a substance in a sample, which includes a method and apparatus for implementing threshold-based correction function.
简言之,本发明提供了一种方法和装置,用于实现用于生物传感器的、基于阈值的校正函数。将样品应用到生物传感器上,获得对待分析物的初级测量值。获得对次级影响的次级测量值,将其与阈值相比较。确定能对被比较的值做出应答的校正函数。将校正函数应用于待分析物的初级测量值,提供经过校正的待分析物值。Briefly, the present invention provides a method and apparatus for implementing a threshold-based correction function for a biosensor. The sample is applied to the biosensor to obtain a primary measurement of the analyte to be analyte. A secondary measure of impact on the secondary is obtained and compared to a threshold. Determine the correction function that responds to the values being compared. Applying the correction function to the primary measurement of the analyte provides a corrected analyte value.
根据本发明的特征,校正方法使用校正曲线,其被提供来针对干扰作用进行校正。校正曲线可以是线性的或非线性的。校正方法提供了高于和低于阈值的不同校正函数。校正函数可以依赖于或不依赖于正在被校正的初级测量值。校正函数可以是线性的或非线性的。According to a feature of the invention, the correction method uses a correction curve, which is provided to correct for disturbing effects. Calibration curves can be linear or non-linear. The correction method provides different correction functions above and below the threshold. The correction function may or may not be dependent on the primary measurement being corrected. Correction functions can be linear or non-linear.
根据本发明的特征,对次级影响的次级测量包括大量的影响,它们可以单独使用或一起组合使用以确定校正函数。例如,次级影响包括温度、血红蛋白和血样品的血细胞比容(hematocrit)浓度,其被确定,并被用于使得次级影响对报道结果的精确度的干扰最小化。According to a feature of the invention, the secondary measure of secondary influences includes a large number of influences which can be used individually or combined together to determine the correction function. For example, secondary effects including temperature, hemoglobin, and hematocrit concentration of blood samples were determined and used to minimize the interference of secondary effects on the accuracy of reported results.
附图说明 Description of drawings
从对附图中阐释的本发明的优选实施方式的以下详细描述,可以最好地理解具有上述和其它目的以及优点的本发明,其中:The present invention, having the above and other objects and advantages, is best understood from the following detailed description of the preferred embodiments of the invention illustrated in the accompanying drawings, in which:
图1是根据本发明的生物传感系统的结构图示意;Fig. 1 is a schematic structural diagram of a biosensing system according to the present invention;
图2是流程图,其展示了根据本发明进行的示例性逻辑步骤,这是用于实现基于阈值的、对次级影响进行校正的方法的步骤,例如在图1的生物传感器系统中校正环境温度的影响;以及FIG. 2 is a flow chart illustrating exemplary logical steps performed in accordance with the present invention for implementing a threshold-based method of correcting for secondary effects, such as correcting for the environment in the biosensor system of FIG. 1 the effect of temperature; and
图3和4是示例性存储(stored)校正曲线,其展示了根据本发明的校正特征。Figures 3 and 4 are exemplary stored calibration curves illustrating calibration features according to the present invention.
具体实施方式 Detailed ways
现在参考附图,图1显示了生物传感器系统的示意结构图,所述生物传感器系统整体被附图标记100所代表,其根据本发明的原则来布置。生物传感器系统100包括微处理器102,其上连接有内存104,用于储存程序和用户数据以及校正曲线,所述校正曲线用于实现根据本发明的、基于阈值的对次级影响的校正。仪表功能(meter function)106与生物传感器108耦联,其被微处理器102可操作地控制,用于记录化验值,例如血糖化验的值。导线110上的开/关输入应答于用户的开/关输入操作,其与微处理器102耦联,用于运行生物传感器系统100的血液化验顺序模式。导线112上的系统特征输入应答于用户输入操作,其与微处理器102耦联,用于选择性地运行生物传感器100的系统特征模式。导线116上示出的热敏电阻114提供了温度信号输入,其与微处理器102耦联,用于探测干扰影响,例如,根据本发明的用于传感器108的温度信息。导线120上示出的信号输入与微处理器102耦联,用于对干扰物质(例如血红蛋白)进行第二次测量,可选地,由仪表功能106所提供。Referring now to the drawings, Figure 1 shows a schematic block diagram of a biosensor system, generally designated by the reference numeral 100, arranged in accordance with the principles of the present invention. The biosensor system 100 comprises a microprocessor 102 to which is connected a memory 104 for storing program and user data as well as a calibration curve for implementing the threshold-based correction for secondary influences according to the invention. A meter function 106 is coupled to a biosensor 108, which is operatively controlled by the microprocessor 102, for recording assay values, such as blood glucose assay values. An on/off input on lead 110 , responsive to a user's on/off input, is coupled to microprocessor 102 for running the blood test sequence mode of biosensor system 100 . A system feature input on lead 112 , responsive to user input, is coupled to microprocessor 102 for selectively operating a system feature mode of biosensor 100 . A thermistor 114 shown on lead 116 provides a temperature signal input that is coupled to the microprocessor 102 for detecting disturbing effects, eg, temperature information for the sensor 108 in accordance with the present invention. A signal input shown on lead 120 is coupled to microprocessor 102 for a second measurement of an interfering substance such as hemoglobin, optionally provided by meter function 106 .
显示器130与微处理器102耦联,用于对用户显示信息,包括化验结果。电池监测功能132与微处理器102耦联,用于探测低或没有的电池条件。警告功能134与微处理器102耦联,用于探测预先设定的系统条件,以及用于对生物传感器系统100的用户产生警告指示。还提供了数据端口或通信界面136,用于将数据耦联到连接的计算机(未示出)上,以及从连接的计算机上耦联数据。微处理器102含有合适的程序,用于运行本发明的方法,如图2所示。A display 130 is coupled to the microprocessor 102 for displaying information to the user, including test results. A battery monitoring function 132 is coupled to the microprocessor 102 for detecting a low or no battery condition. A warning function 134 is coupled to the microprocessor 102 for detecting predetermined system conditions and for generating warning indications to a user of the biosensor system 100 . A data port or communication interface 136 is also provided for coupling data to and from an attached computer (not shown). Microprocessor 102 contains suitable programming for running the method of the present invention, as shown in FIG. 2 .
生物传感器系统100以简化形式显示,但是足以理解本发明。展示的生物传感器系统100不用于暗示结构或功能上的限制。本发明可与多种硬件实现工具和系统一起使用。Biosensor system 100 is shown in simplified form, but sufficient to understand the invention. The illustrated biosensor system 100 is not intended to imply structural or functional limitations. The invention can be used with a variety of hardware implementation tools and systems.
根据本发明,生物传感器100运行优选实施方式的校正方法,例如,减少温度偏差,其具有如下表1所示,以及如图2所阐释和描述的通用形式。本发明提供了一种算法校正方法,其有利地改进了诊断化学化验的精确度,这是通过校正次级影响,例如干扰物质或温度影响来实现的。According to the present invention, the biosensor 100 operates a preferred embodiment calibration method, eg, reducing temperature deviation, which has a general form as shown in Table 1 below, and as illustrated and described in FIG. 2 . The present invention provides an algorithmic correction method that advantageously improves the accuracy of diagnostic chemistry assays by correcting for secondary effects, such as interfering substances or temperature effects.
应当理解,本发明可被用于任何系统,电化学的或光学的,其测量待分析物浓度作为初级测量值,然后用对干扰物质(例如,血红蛋白)或干扰影响(例如,温度)的第二次测量值来补偿次级影响,并且提高报道结果的精确度。It should be understood that the present invention can be used in any system, electrochemical or optical, that measures the analyte concentration as a primary measurement and then uses a secondary measurement of interfering substances (e.g., hemoglobin) or interfering influences (e.g., temperature). Secondary measurements are used to compensate for secondary effects and improve the accuracy of reported results.
使得来自红血球的体积分数(volume fraction)或血细胞比容对于报道结果的精确度的干扰最小化,也是人们想要的。全血的导电率或阻抗取决于血细胞比容的浓度。仪表功能120可被用于测量信号输入线120上样品流体的电阻,测量值可有利地用于针对血细胞比容对报道结果的影响进行校正。例如,测得的电阻可有利地用于估计血样血细胞比容的浓度,然后用于针对血细胞比容的影响对测量值加以校正,以确定血液中目标物质的浓度。本发明提供了一种算法校正方法,其可以有利地提高诊断化学化验的精确度,这是通过针对次级影响加以校正来实现的,所述次级影响包括来自血细胞比容的干扰和温度的影响。It is also desirable to minimize interference from volume fraction or hematocrit of red blood cells on the accuracy of reported results. The conductivity or impedance of whole blood depends on the concentration of hematocrit. The meter function 120 can be used to measure the resistance of the sample fluid on the signal input line 120, and the measured value can advantageously be used to correct for the effect of hematocrit on the reported results. For example, the measured electrical resistance can advantageously be used to estimate the hematocrit concentration of a blood sample, which is then used to correct the measurement for hematocrit effects to determine the concentration of a substance of interest in the blood. The present invention provides an algorithmic correction method that advantageously improves the accuracy of diagnostic chemistry assays by correcting for secondary effects including interference from hematocrit and temperature Influence.
根据本发明,该算法校正方法使用校正曲线,例如,如图3和4中所阐释和描述的,其可适于对任何完善确立的干扰影响加以校正。校正曲线可以是线性的或非线性的。算法校正方法具有如下特征:可按照下文所述仅改变方程式的系数,来对其加以修正。首先,可以提供高于和低于阈值的不同校正函数。第二,校正函数可以依赖或不依赖将被校正的初级测量值。第三,用于校正的函数可以是线性的或非线性的。According to the invention, the algorithmic correction method uses a correction curve, eg as illustrated and described in Figures 3 and 4, which can be adapted to correct for any well-established interference effects. Calibration curves can be linear or non-linear. The algorithmic correction method has the feature that it can be corrected by changing only the coefficients of the equations as described below. First, different correction functions above and below a threshold can be provided. Second, the correction function may or may not depend on the primary measurements to be corrected. Third, the function used for correction can be linear or non-linear.
表1:通用校正算法表Table 1: General correction algorithm table
步骤1.获得初级测量值(Gn)。Step 1. Obtain primary measurements (Gn).
步骤2.获得用于校正Gn(T)的次级测量值Step 2. Obtain secondary measurements for correcting Gn(T)
步骤3A如果T≤Tc,那么:Step 3A If T≤Tc, then:
1.A=f(Gn)1. A=f(Gn)
2.Cn=F*T+A*(Tc-T)+H2. Cn = F*T+A*(Tc-T)+H
步骤3B如果T>Tc,那么:Step 3B If T>Tc, then:
3.I=f2(GN)3. I=f 2 (G N )
4.Cn=F*T+I*(T-Tc)+H4. Cn = F*T+I*(T-Tc)+H
5.Gc=(GN/Gn)5.G c =(G N /G n )
其中:in:
Gn=未校正的待分析物浓度测量值; Gn = uncorrected analyte concentration measurement;
T=用于校正初级测量值的次级测量值;T = secondary measurement used to correct the primary measurement;
Tc=决定点或阈值,高于或低于阈值的次级测量值有利地可使用不同的校正函数; Tc = decision point or threshold, above or below which secondary measurements may advantageously use different correction functions;
Gc=最终校正结果;以及G c = final calibration result; and
A、I、F、H是控制校正线幅度(magnitude)或限定校正曲线的系数。A, I, F, H are coefficients that control the magnitude of the calibration line or define the calibration curve.
现在参照图2,其展示了根据本发明进行的示例性逻辑步骤,这是用于实现基于阈值的、对次级影响进行校正的方法的步骤,例如在生物传感器系统100中校正环境温度的影响。如方块200所示,插入带(strip),然后等到待应用的样品运行,如方块202所示。如方块204所示,获得初级测量值Gn。然后如方块206所示,获得用于校正Gn(T)的次级测量值T。然后如决定块208所示,将次级测量值T与阈值Tc相比。如果次级测量值T小于或等于阈值Tc,那么如方块210所示,确定用于控制校正幅度的系数A,其中,A=f(Gn)。然后如方块210所示,计算校正值Cn,其中,Cn=F*T+A*(Tc-T)+H。反过来,如果次级测量值T高于阈值Tc,那么如方块214所示,确定用于控制校正幅度的系数I,其中,I=f2(Gn)。然后如方块216所示来计算校正值Cn,其中,Cn=F*T+I*(T-Tc)+H。如方块218所示,计算出最终的校正结果Gc,其中,Gc=Gn/Cn,以完成校正算法,如方块220所示。Referring now to FIG. 2 , which illustrates exemplary logical steps performed in accordance with the present invention, which are steps for implementing a threshold-based method of correcting for secondary effects, such as the effect of ambient temperature in a biosensor system 100 . Insert the strip as shown at block 200 and then wait until the sample run to be applied is shown at block 202 . As represented by
现在参考图3和4,其分别展示了一般性地被附图标记300和400所代表的第一个和第二个例子,其中展示了校正的示例性理论线。在图3和4中,百分比(%)校正被展示在纵轴上,次级测量值T被展示在横轴上。阈值Tc由标记有Tc的线所代表。Referring now to FIGS. 3 and 4 , there are shown first and second examples, generally designated by the
图3展示了不同初级测量浓度Gn下的等容(isometric)校正,其中校正值依赖于初级测量浓度Gn。如图3中例子300所示,当次级测量值T高于或低于阈值Tc时,校正值Cn的幅度随待分析物浓度Gn而改变。图4展示了不同初级测量浓度Gn下的等容校正线,其中,在高于阈值Tc的情况下,校正值依赖于初级测量浓度Gn,而在低于或等于阈值Tc的情况下,校正值恒定或不依赖于初级测量浓度Gn。Figure 3 shows the isometric correction for different primary measurement concentrations Gn, where the correction value is dependent on the primary measurement concentration Gn. As shown in example 300 in FIG. 3, the magnitude of the correction value Cn varies with the analyte concentration Gn when the secondary measurement T is above or below the threshold Tc. Figure 4 shows the isovolumic correction lines at different primary measured concentrations Gn, where, above the threshold Tc, the correction value depends on the primary measured concentration Gn, while below or equal to the threshold Tc, the correction value Constant or independent of the primary measured concentration Gn.
已参照附图中展示的本发明的实施方式的细节,对本发明进行了描述,这些细节并不用于限制本发明的范围,本发明的范围如所附的权利要求所示。The invention has been described with reference to details of its embodiment shown in the drawings, these details not being intended to limit the scope of the invention as shown in the appended claims.
Claims (21)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55790704P | 2004-03-31 | 2004-03-31 | |
US60/557,907 | 2004-03-31 | ||
US60957004P | 2004-09-13 | 2004-09-13 | |
US60/609,570 | 2004-09-13 | ||
PCT/US2005/011077 WO2005098424A1 (en) | 2004-03-31 | 2005-03-31 | Method and apparatus for implementing threshold based correction functions for biosensors |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1938589A CN1938589A (en) | 2007-03-28 |
CN1938589B true CN1938589B (en) | 2011-12-28 |
Family
ID=37955194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800102926A Expired - Fee Related CN1938589B (en) | 2004-03-31 | 2005-03-31 | Method and apparatus for implementing threshold based correction functions for biosensors |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1938589B (en) |
ZA (1) | ZA200608724B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8260556B2 (en) * | 2008-08-21 | 2012-09-04 | Bio-Rad Laboratories, Inc. | Calibration surface method for determination on of analyte ratios |
JP5713465B2 (en) * | 2012-09-14 | 2015-05-07 | 株式会社タニタ | Biosensor calibration method |
US9958410B2 (en) * | 2013-03-14 | 2018-05-01 | Ascensia Diabetes Care Holdings Ag | Normalized calibration of analyte concentration determinations |
CN104750132B (en) * | 2015-04-21 | 2017-03-15 | 三诺生物传感股份有限公司 | A kind of test temperature bearing calibration, controller and test temperature correction system |
FI128124B (en) * | 2016-04-25 | 2019-10-15 | Teknologian Tutkimuskeskus Vtt Oy | Optical sensor, system and methods |
CN109682968B (en) * | 2018-11-08 | 2022-03-11 | 上海艾瑞德生物科技有限公司 | Temperature correction method for quantitative detection test signal of fluorescence immunoassay strip |
CN114660149A (en) * | 2022-02-23 | 2022-06-24 | 爱奥乐医疗器械(深圳)有限公司 | Electrochemical test paper and detection method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1412548A (en) * | 2001-10-10 | 2003-04-23 | 生命扫描有限公司 | Detection of proper sampling volume from biological sensor device |
-
2005
- 2005-03-31 CN CN2005800102926A patent/CN1938589B/en not_active Expired - Fee Related
-
2006
- 2006-10-19 ZA ZA200608724A patent/ZA200608724B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1412548A (en) * | 2001-10-10 | 2003-04-23 | 生命扫描有限公司 | Detection of proper sampling volume from biological sensor device |
Also Published As
Publication number | Publication date |
---|---|
CN1938589A (en) | 2007-03-28 |
ZA200608724B (en) | 2008-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11584945B2 (en) | Method and apparatus for implementing threshold based correction functions for biosensors | |
JP4124513B2 (en) | Method and apparatus for correcting the effect of ambient temperature in a biosensor | |
JP3413323B2 (en) | Method and apparatus for measuring the concentration of an analyte utilizing an amperometric sensor | |
US10067082B2 (en) | Biosensor for determining an analyte concentration | |
JP5455924B2 (en) | Speed reading gate amperometry | |
ZA200608724B (en) | Method and apparatus for implementing threshold based correction functions for biosensors | |
US20170038331A1 (en) | System and method for compensating sample-related measurements based on polarization effects of test strips | |
CA2416606C (en) | Apparatus and method for reduction of bias in amperometric sensors | |
MXPA06008843A (en) | Oxidizable species as an internal reference for biosensors and method of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1102097 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1102097 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111228 |